
News
Glaucoma specialist Joel Solano, MD, connects patients diagnosed with glaucoma with digital health solutions that can help prevent blindness and vision loss.

News
Glaucoma specialist Joel Solano, MD, connects patients diagnosed with glaucoma with digital health solutions that can help prevent blindness and vision loss.

Kriya is developing a one-time gene therapy designed to block complement C3 and C5, which are clinically validated substrates targeted by FDA approved therapies, to delay the progression of geographic atrophy.

Efficacy of treatment option is also confirmed in pediatric population in India.

The Lasker-DeBakey Clinical Medical Research Award, dubbed ‘America’s Nobel,’ recognizes the wide use of optical coherence tomography to manage eye disease, prevent blindness.

The investigators found that the corrected distance visual acuity (CDVA) in the amblyopic eye improved significantly in all patients regardless of age

Sequential customised therapeutic keratectomy (SCTK) improves visual quality by eliminating superficial corneal high order aberrations

We spoke with researchers and industry professionals at the 2023 ASRS meeting in Seattle, Washington. We asked them, "What do you wish patients knew about eye health?" Here's what Michael Ip, MD, Shawn Kavoussi, MD, and Megan Baldwin, PhD, had to say!

Ocuphire Pharma and Viatris developed the drug together for the reversal of pharmacologically-induced mydriasis (RM) produced by adrenergic agonist or parasympatholytic agents

The company announced its previously announced agreement to divest its late-stage ophthalmic assets to Laboratoires Théa S.A.S. has been terminated.

Ocuphire Pharma and Viatris developed the drug together for the reversal of pharmacologically-induced mydriasis (RM) produced by adrenergic agonist or parasympatholytic agents.

Preservative-free Iyuzeh, launched more than 10 years ago, currently is available in 46 countries, mostly under the brand name Monoprost, with about 1.5 million patients treated monthly, according to the company.

Discover how advocacy can impact your clinical work and ultimately patient care.

Highlighting the benefits of Iridex's updated P3 Probe and Cyclo G6® Laser software for MicroPulse® transscleral laser therapy. The redesigned probe improves ergonomics and visibility, while the user-friendly software ensures precise, reproducible glaucoma treatments.

Study finds 45% of injuries involve the eyes.

We asked, "What do you wish patients knew about eye health?" Here's what Durga Borkar, MD, MMCi, Aaron Lee, MD, and Carl Dazig, MD, had to say!

Peter J. McDonnell, MD, and Neda Shamie, MD, discuss the transformative impact of minimally invasive glaucoma surgery (MIGS) on glaucoma care and its integration with cataract surgery, sharing insights and practical tips for ophthalmologists.

Procedure corrects small-angle strabismus and removes need for prism glasses

Sometimes, the best job for you is the one you create.

On the 'Negotiations' episode of RWO: The Podcast, Dr. Lisa Nijm joins Drs. Nicole Bajic and Grayson Armstrong to discuss personal experiences with contract negotiation.

Experts in all aspects of retinal care will gather at the RAI Amsterdam Convention Centre, located in the Zuidas business district of the city, which is a short distance from historic Amsterdam with is canals, museums, and shops

According to a news release, the J-code for SYFOVRE will become effective on October 1, 2023.

The Orbis Flying Eye Hospital will return to Zambia for a 3-week training project in Lusaka coinciding with World Sight Day on October 12.

According to the companies, the partnership will roll out a proprietary system that has earned FDA breakthrough designation, one of the few ophthalmic devices to achieve this status in almost a decade.


News
To educate patients on the disease, the company has enlisted the help of actor Eric Stonestreet and his mother, Jamey.

Corneal wound burn is a critical, yet often overlooked, complication in cataract surgery. Recognizing early signs is crucial.

Kiora CEO Brian Strem, PhD, offers an update on the development of KIO-301, a molecule that selectively targets retinal ganglion cells, giving them the ability to sense light.

News
To educate patients on the disease, the company has enlisted the help of actor Eric Stonestreet and his mother, Jamey.

Attendees can take advantage of many satellite symposia sponsored by industry. Experts from around the world will present during the symposia.

As a gold medalist with profound vision loss, she will lead advocacy efforts for people with glaucoma that are designed to empower patients to participate actively in their glaucoma treatment journey